IDEX Expects Q3 Organic Sales To Decline 7-8%, Adjusted EPS Of $1.84- $1.89 (Consensus $2.16)
Portfolio Pulse from Benzinga Newsdesk
IDEX Corporation expects its Q3 organic sales to decline by 7-8%. The company also anticipates an adjusted EPS of $1.84-$1.89, which is below the consensus estimate of $2.16.
July 26, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
IDEX Corporation's Q3 organic sales are expected to decline by 7-8%, and its adjusted EPS is forecasted to be $1.84-$1.89, lower than the consensus estimate of $2.16.
The company's expected decline in Q3 organic sales and lower-than-expected adjusted EPS could negatively impact its stock price in the short term. Investors may react to the lower earnings forecast by selling their shares, leading to a potential decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100